Valo Therapeutics Oy
2768695-4ActiveDeveloping novel peptide-coated oncolytic virus immunotherapies for cancer.
Biotechnology Companyvalotx.com
Översikt
- Okänt
- Anställda
- Okänt
- Omsättning
- 2016
- Grundat
Nyckelbeslutsfattare
Malcolm K. Brenner
Member of the Scientific and Clinical Advisory Board
Lukasz Kuryk
VP Translational and Clinical Science, IP Manager
Andrew Dean
Member of the Board
Jeffrey Bockman
Member of the Scientific and Clinical Advisory Board
+17 fler kontakter i Funnelfeedr
Beskrivning
Valo Therapeutics (ValoTx) is a biotechnology company spun out from the University of Helsinki, specializing in cancer immunotherapy. The organization focuses on developing novel treatments by uniquely combining oncolytic virus therapy, peptide vaccination, and viral vector approaches. Their core pr...
Sox Therapeutics AB